Welcome to our dedicated page for ELEKTA B SHS news (Ticker: EKTAF), a resource for investors and traders seeking the latest updates and insights on ELEKTA B SHS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ELEKTA B SHS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ELEKTA B SHS's position in the market.
Elekta will present its second quarter 2021/22 results on November 25 at 10:00 a.m. CET, following the release of its interim report at 7:30 a.m. CET on the same day. The presentation will be conducted by President and CEO Gustaf Salford and CFO Johan Adebäck, including a Q&A session. Participants can join via a phone conference or watch the webcast. Elekta is a leader in precision radiation therapy, committed to innovative solutions in cancer care.
Elekta announced that its Elekta Harmony radiation therapy system has received U.S. FDA 510(k) clearance, enabling U.S. clinics to treat a broad range of indications.
The system balances productivity and precision, addressing the increasing cancer burden, exacerbated by Covid-19 delays in diagnoses.
Key features include reduced patient setup time by up to 50%, workflow enhancements, and a versatile design for challenging treatments like SBRT, aimed at enhancing treatment access across networks.
Elekta reported strong order growth in Q4 2021, totaling SEK 5,379 M (up 18% in constant currency). Despite challenges due to Covid, net sales rose slightly to SEK 3,667 M. Full-year performance showed gross order intake at SEK 17,411 M (up 6%) and net sales at SEK 13,763 M. EBITA increased to SEK 2,709 M with a margin of 19.7%. A proposed dividend of SEK 2.20 per share was announced. The company aims for over 7% net sales CAGR until 2024/25, and plans to expand EBIT margins.
Elekta has appointed Johan Adebäck as the permanent Chief Financial Officer, effective immediately. Adebäck has served as the Acting CFO since June 2, 2020, and has an extensive background in finance, including his previous role as Group Treasurer since 2004. Elekta's President and CEO, Gustaf Salford, praised Adebäck for his integrity and proficiency. Adebäck holds a Bachelor's degree in Business Administration and Economics from Stockholm University. This announcement was made on February 25, 2021, as part of Elekta's compliance with the Securities Markets Act.
Elekta announced the establishment of a permanent office in Cairo, Egypt, to address the regional shortage of radiotherapy systems. The company has signed an agreement to acquire the oncology division of its previous distributor, Horizon for Medical Appliances, aiming to enhance customer service. This new office will serve as a hub for N. Africa’s population of 200 million, offering improved precision radiation therapy. The office is set to open in March 2021. Elekta has a long-standing presence in Egypt, contributing to cancer treatment advancements.
Elekta announced a partnership with the U.S. Department of Veterans Affairs to integrate its ProKnow cloud solution into the VA's radiation oncology network. This collaboration aims to enhance data accessibility across 41 VA facilities, improving treatment management for over 45,000 veterans receiving radiotherapy annually. ProKnow's capabilities will allow for real-time data analysis and standardization of care practices. Elekta's commitment to veterans is further emphasized as many of its employees are veterans themselves, making this initiative particularly meaningful.
FAQ
What is the market cap of ELEKTA B SHS (EKTAF)?
